Clinical Trial Update: A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood [Phase 4]

View source ↗

Summary

Completed Phase 4 multicentre randomized trial assessing the effects of Saizen on cardiac function in growth hormone deficient individuals transitioning from ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dwarfism
• Growth Hormone Deficiency

Drugs mentioned

• Saizen (somatropin)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Dwarfism, Growth Hormone Deficiency | Phase 4 | Status: COMPLETED